AVTE |
Aerovate Therapeutics, Inc. |
Director, 10%+ Owner |
$198 M |
|
|
Jun 17, 2024 |
ITOS |
iTeos Therapeutics, Inc. |
Former 10% Owner |
$137 M |
+$100 M |
+270% |
May 10, 2024 |
NKTX |
Nkarta, Inc. |
Director, 10%+ Owner |
$131 M |
+$60 M |
+85.1% |
Jun 13, 2024 |
TYRA |
Tyra Biosciences, Inc. |
Director, 10%+ Owner |
$130 M |
|
|
May 29, 2024 |
CTKB |
Cytek Biosciences, Inc. |
Director, 10%+ Owner |
$127 M |
|
|
Mar 14, 2022 |
ANTX |
AN2 Therapeutics, Inc. |
10%+ Owner |
$98.2 M |
+$16 M |
+19.5% |
Aug 18, 2023 |
PEPG |
PepGen Inc. |
Director, 10%+ Owner |
$97.7 M |
+$27.2 M |
+38.6% |
Jun 20, 2024 |
SPRY |
ARS Pharmaceuticals, Inc. |
Director, 10%+ Owner |
$97.5 M |
+$44.7 M |
+84.8% |
Jun 20, 2024 |
WVE |
Wave Life Sciences Ltd. |
Director, 10%+ Owner |
$91 M |
+$10 M |
+12.3% |
Dec 11, 2023 |
ETNB |
89bio, Inc. |
Director, 10%+ Owner |
$83.7 M |
+$30.7 M |
+58% |
Mar 4, 2024 |
ACRV |
Acrivon Therapeutics, Inc. |
Director, 10%+ Owner |
$67.3 M |
|
|
Jun 20, 2024 |
JANX |
Janux Therapeutics, Inc. |
Director, 10%+ Owner |
$65.1 M |
+$77.4 M |
|
Jun 26, 2024 |
MLYS |
Mineralys Therapeutics, Inc. |
Director |
$47.7 M |
|
|
May 22, 2024 |
KALA |
KALA BIO, Inc. |
10%+ Owner |
$47.4 M |
|
|
May 26, 2022 |
ABOS |
Acumen Pharmaceuticals, Inc. |
Director, 10%+ Owner |
$45.3 M |
+$40 M |
+759% |
Jun 10, 2024 |
FULC |
Fulcrum Therapeutics, Inc. |
10%+ Owner |
$38.4 M |
|
|
Jan 20, 2023 |
ELVN |
Enliven Therapeutics, Inc. |
Former 10% owner |
$32.1 M |
|
|
Feb 23, 2023 |
SLDB |
Solid Biosciences Inc. |
Director, 10%+ Owner |
$23.2 M |
+$5 M |
+27.5% |
Jan 11, 2024 |
PNT |
POINT Biopharma Global Inc. |
Director |
$13.7 M |
|
|
Jun 29, 2021 |
GRPH |
LENZ Therapeutics, Inc. |
Director, 10%+ Owner |
$13.5 M |
|
|
Mar 21, 2024 |
ELYM |
Eliem Therapeutics, Inc. |
Director, 10%+ Owner |
$11 M |
+$50 M |
|
Jun 27, 2024 |
RXST |
RxSight, Inc. |
10%+ Owner |
$10.3 M |
|
|
Aug 3, 2021 |
BDTX |
Black Diamond Therapeutics, Inc. |
Director |
$8.77 M |
|
|
Jul 5, 2023 |
ICVX |
Icosavax, Inc. |
Director, 10%+ Owner |
$0 |
|
|
Feb 19, 2024 |
BOLD |
Boundless Bio, Inc. |
10%+ Owner |
|
|
|
Apr 2, 2024 |
CDTX |
Cidara Therapeutics, Inc. |
Director |
|
|
|
Apr 26, 2024 |
DICE |
DICE Therapeutics, Inc. |
Former 10% owners and Director |
|
|
|
Aug 9, 2023 |
FMTX |
Forma Therapeutics Holdings, Inc. |
Director, 10%+ Owner |
|
|
|
Oct 14, 2022 |
STSA |
Satsuma Pharmaceuticals, Inc. |
Former 10% Owner |
|
|
|
Jun 8, 2023 |
VOR |
Vor Biopharma Inc. |
Director, 10%+ Owner |
|
|
|
May 23, 2024 |
HOWL |
Werewolf Therapeutics, Inc. |
Director, 10%+ Owner |
|
|
|
May 24, 2024 |